Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
09/2003
09/11/2003US20030170826 Fusion proteins include cell penetrating domain linked to transmembrane domain
09/11/2003US20030170786 Vascular endothelial growth factor 2
09/11/2003US20030170785 CDNA encoding the human alpha2 delta4 calcium channel subunit
09/11/2003US20030170754 Anticancer agents; diagnosis of prostate cancer
09/11/2003US20030170736 Adjustment of cell differentiation; medical diagnosis
09/11/2003US20030170722 Signal transduction; anticancer agents, antiinflammatory agents, autoimmune disease, antiarthritic agents
09/11/2003US20030170714 Polypeptides; activation lymphocytes
09/11/2003US20030170708 Screening for mutants; primer amplification
09/11/2003US20030170700 Secreted and cell surface polypeptides affected by cholesterol and uses thereof
09/11/2003US20030170690 Immunocellular receptors related to neurological disorders and therapeutic uses thereof
09/11/2003US20030170663 Nucleotide sequence of the Mycoplasma genitalium genome, fragments thereof, and uses thereof
09/11/2003US20030170655 Mus101 and homologue thereof
09/11/2003US20030170648 Autoimmune diseases; inflammatory bowel disease; multiple sclerosis; rheumatic diseases; modulate gene expression
09/11/2003US20030170628 Forsenic analysis; medical diagnosis; chromosome markers
09/11/2003US20030170614 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
09/11/2003US20030170276 Modified msbB gene
09/11/2003US20030170274 Activation of HCV-specific T cells
09/11/2003US20030170273 Type 1 interferon inducers, such as double-stranded RNA, in combination with antigen delivery systems and/or immunostimulatory molecules for enhancing the immune response of a coadministered antigen
09/11/2003US20030170270 Nucleic acid encoding an infectious, nonpathogenic PCV1, which contains an immunogenic open reading frame gene of a pathogenic PCV2 in place of an ORF gene of the PCV1 nucleic acid molecule.
09/11/2003US20030170268 Administering a fusion protein of a heat shock protein or immunostimulatory fragment and a human papilloma virus protein or an antigenic fragment; or a nucleic acid coding the fusion protein
09/11/2003US20030170266 Complex of a paramyxovirus-derived negative-strand single-stranded RNA modified not to express an envelope protein of paramyxoviruses, and proteins that bind to it
09/11/2003US20030170259 Chlamydia antigens and corresponding dna fragments and uses thereof
09/11/2003US20030170258 Transmucosally administering an epitope which is located in close proximity to said immune response, wherein said modulation comprises induction of oral tolerization to said antigen.
09/11/2003US20030170233 Treating Autoimmune Diseases with Humanized Anti-CD40L Antibody
09/11/2003US20030170216 SYN3 compositions and methods
09/11/2003US20030170213 Methods and compositions for enhancing cognitive function using morphogenic proteins
09/11/2003US20030170211 For delivering alphavirus replicon DNA into an animal or animal cells with the replicon encoding one or more heterologous genes to be expressed in the animal or the animal cells
09/11/2003US20030170210 Use of paramyxovirus vector in gene transfer into blood vessel
09/11/2003US20030170209 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization
09/11/2003US20030170208 To promote osteogenesis and therefore uses include fracture healing and repair and acceleration of fracture healing
09/11/2003US20030170203 Death domain containing receptors
09/11/2003US20030170177 Useful as vehicle for gene therapy, and in imaging
09/10/2003EP1342795A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/10/2003EP1342728A1 Radiosensitivity enhancers in radiotherapy for cancer and nucleic acids and proteins enhancing radiosensitivity
09/10/2003EP1342477A1 Cationic vehicle: dna complexes and their use in gene therapy
09/10/2003EP1341920A2 Human elongase genes and uses thereof
09/10/2003EP1341917A2 26199, 33530, 33949, 47148, 50226, and 58764, human transferase family members and uses therefor
09/10/2003EP1341915A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue
09/10/2003EP1341914A2 Regulation of angiogenesis with zinc finger proteins
09/10/2003EP1341909A2 A method for in vitro molecular evolution of protein function
09/10/2003EP1341904A1 Zipper protein kinase and uses thereof
09/10/2003EP1341815A2 Compositions and methods related to the minn1 tumor suppressor gene and protein
09/10/2003EP1341807A2 Interferon-alpha induced gene
09/10/2003EP1341565A2 Drug delivery compositions and coated medical devices
09/10/2003EP1341558A2 A novel system for the evaluation of the activity and/or specificity of a viral component
09/10/2003EP1341540A2 Tyrosine kinase inhibitors
09/10/2003EP1124572B1 Genes and proteins predictive and therapeutic for renal disease and associated disorders
09/10/2003EP0885237B1 Oligonucleotide analogues
09/10/2003CN1441841A Stimulation of cellular regeneration and differentiation in inner ear
09/10/2003CN1441807A Hepatitis B core antigen fusion proteins
09/10/2003CN1120707C Ligands to enhance cellular uptake of biomolecules
09/09/2003US6617450 P-glycoproteins and uses thereof
09/09/2003US6617440 Isolated polynucleotide that promotes transcription; gene expression inhibition; used for engineering animals with increased lean meat and promoting muscle growth; treating muscular disorders
09/09/2003US6617432 Useful as markers in diagnosing, monitoring the stage of malignancy and treating prostate cancer
09/09/2003US6617430 Ataxin-2 binding proteins
09/09/2003US6617171 Detecting immunological defects in mammal; obtain sample tissue from mammal, detect proteasome activity, reduction in proteasome activty indicates immunological defect
09/09/2003US6617151 Method of closing a cell containment device with a wet seal
09/09/2003US6617135 Multiple cytokine protein complexes
09/09/2003US6617129 Isolated nucleic acid; prostate-specific gene therapy method; diagnosis and treatment of prostate cancer
09/09/2003US6617122 Contacting a compound with a polypeptide, in the presence of adenosine triphosphate (ATP) and detecting its binding or hydrolysis of ATP; use in treatment of coronary artery disease
09/09/2003US6617121 Snail, new tumoral progression marker and target protein of new antitumoral compounds
09/09/2003US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent
09/09/2003US6616869 Process for preparing microparticles through phase inversion phenomena
09/04/2003WO2003072824A1 Markers for predicting pathological conditions in haert failure and method of using the same
09/04/2003WO2003072821A2 Method and nucleic acids for the analysis of a colon cell proliferactive disorder
09/04/2003WO2003072820A2 Method and nucleic acids for the analysis of colon cell proliferative disorders
09/04/2003WO2003072812A2 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
09/04/2003WO2003072799A2 Brother of the regulator of imprinted sites (boris)
09/04/2003WO2003072779A1 Method of using pituitary-specific genes
09/04/2003WO2003072771A2 Method of preparing a treatment product using a togaviridae expression construct
09/04/2003WO2003072756A2 Cloning and characterization of slc26a8 and slc26a11 anion exchangers
09/04/2003WO2003072751A2 Expression system for human brain-specific voltage-gated sodium channel, type 1
09/04/2003WO2003072741A2 Therapeutic regulation of deoxyribonuclease-1-like-3 activity
09/04/2003WO2003072732A2 Methods of making hypermutable cells using pmsr homologs
09/04/2003WO2003072727A2 EGFRvIII SPECIFIC MONOCLONAL ANTIBODY AND EGFRvIII RIBOZYMES AND USE TO DETECT, TREAT OR PREVENT EGFRvIII ASSOCIATED CANCER
09/04/2003WO2003072725A2 Recombinant negative strand virus rna expression systems and vaccines
09/04/2003WO2003072715A2 Gasp1: a follistatin domain containing protein
09/04/2003WO2003072711A2 Method of using modified oligonucleotides for hepatic delivery
09/04/2003WO2003072704A2 RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
09/04/2003WO2003072703A2 Adenoviral vector with replication-dependent transgene expression
09/04/2003WO2003072637A1 Carbohydrate-modified polymers, compositions and uses related thereto
09/04/2003WO2003072591A1 Trpm-2 antisense therapy using an oligonucleotide having 2'-o-(2-methoxyl)ethyl modifications
09/04/2003WO2003072126A2 Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems
09/04/2003WO2003072114A1 Vascular therapeutics
09/04/2003WO2003072045A2 Treatment and prevention of aids progression and methods of using same
09/04/2003WO2003072029A2 Methods of extending corneal graft survival
09/04/2003WO2003072016A2 Pharmaceutical compositions in particulate form
09/04/2003WO2003044187A3 Emulsion compositions
09/04/2003WO2003030922A3 Bestrophin and bestrophin homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2003029778A3 Novel secreted proteins and their uses
09/04/2003WO2003025162A3 Regulation of human prolyl 4-hydroxylase alpha subunit precursor
09/04/2003WO2003014366A3 Rna amplification system using plant components in animal cells
09/04/2003WO2003013647A3 Electrodes coated with treating agent and uses thereof
09/04/2003WO2002099107A3 Regulation of human trace amine receptor ta5
09/04/2003WO2002097395A3 P-cadherin as a target for anti-cancer therapy
09/04/2003WO2002094870A8 Proteins and nucleic acids encoding same
09/04/2003WO2002079238A3 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis
09/04/2003WO2002072127A3 Modulation of smooth muscle cell proliferation by vegf-x or antagonists thereof
09/04/2003WO2002062823A3 Peptides for facilitating composite receptor expression and translocation of macromolecules
09/04/2003WO2002055698A3 Transcriptional mediators of blood vessel development and endothelial differentiation
1 ... 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 ... 870